Ogawa A, Satoh T, Tamura Y, Fukuda K, Matsubara H. Survival of Japanese patients with idiopathic/heritable pulmonary arterial hypertension. Am J Cardiol. 2017;119:1479–84.

Article  PubMed  Google Scholar 

Shirai Y, Yasuoka H, Okano Y, Takeuchi T, Satoh T, Kuwana M. Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort. Rheumatology. 2012;51:1846–54.

Article  PubMed  Google Scholar 

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RM, Brida M, et al. 2022ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618–731.

Article  CAS  PubMed  Google Scholar 

Naeije R, Richter MJ, Rubin LJ. The physiological basis of pulmonary arterial hypertension. Eur Respir J. 2022;59(6):2102334.

Article  PubMed  PubMed Central  Google Scholar 

Frost A, Badesch D, Gibbs JS, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53:1801904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lau EM, Manes A, Celermajer DS, Galiè N. Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J. 2011;32:2489–98.

Article  PubMed  Google Scholar 

Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, et al. Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension. Sci Rep. 2022;12:5289.

Article  PubMed  PubMed Central  Google Scholar 

Distler O, Ofner C, Huscher D, Jordan S, Ulrich S, Stähler G, et al. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis. Rheumatology (Oxford). 2024;63(4):1139–46.

Article  CAS  PubMed  Google Scholar 

Avouac J, Airò P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol. 2010;37:2290–8.

Article  PubMed  Google Scholar 

Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest. 2010;137:376–87.

Article  PubMed  Google Scholar 

Ho JE, Zern EK, Lau ES, Wooster L, Bailey CS, Cunningham T, et al. Exercise pulmonary hypertension predicts clinical outcomes in patients with dyspnea on effort. J Am Coll Cardiol. 2020;75:17–26.

Article  PubMed  PubMed Central  Google Scholar 

van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/european league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–55.

Article  PubMed  Google Scholar 

Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med. 2014;190(3):252–7.

Article  PubMed  Google Scholar 

Naeije R, Chin K. Differentiating precapillary from postcapillary pulmonary hypertension. Circulation. 2019;140(9):712–4.

Article  PubMed  Google Scholar 

Naeije R, Tonelli AR. Pulmonary artery wedge pressure in the diagnosis of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2024;209(3):242–4.

Article  PubMed  Google Scholar 

Zeder K, Banfi C, Steinrisser-Allex G, Maron BA, Humbert M, Lewis GD, et al. Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review. Eur Respir J. 2022;60:2103181.

Article  PubMed  PubMed Central  Google Scholar 

Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev. 2020;19(3):102458.

Article  PubMed  Google Scholar 

Cutolo M, Smith V. Detection of microvascular changes in systemic sclerosis and other rheumatic diseases. Nat Rev Rheumatol. 2021;17(11):665–77.

Article  PubMed  Google Scholar 

Smith V, Vanhaecke A, Herrick AL, Distler O, Guerra MG, Denton CP, et al. Fast track algorithm: how to differentiate a scleroderma pattern from a non-scleroderma pattern. Autoimmun Rev. 2019;18(11):102394.

Article  PubMed  Google Scholar 

Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, MacDonald PS, Hopper I, et al. National heart foundation of Australia and cardiac society of Australia and new zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018. Heart Lung Circ. 2018;27(10):1123–208.

Article  PubMed  Google Scholar 

Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, Evidence-Based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138(9):861–70.

Article  PubMed  PubMed Central  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.

Article  CAS  PubMed  Google Scholar 

Fox BD, Shimony A, Langleben D, Hirsch A, Rudski L, Schlesinger R, et al. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J. 2013;42(4):1083–91.

Article  PubMed  Google Scholar 

Maron BA, Bortman G, De Marco T, Huston JH, Lang IM, Rosenkranz SH, et al. Pulmonary hypertension associated with left heart disease. Eur Respir J. 2024;64(4):2401344.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coghlan JG, Denton CP, Grünig E, Bonderman D, Distler O, Khanna D, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73:1340–9.

Article  PubMed  Google Scholar 

Hinchcliff M, Fischer A, Schiopu E, Steen VD, PHAROS Investigators. Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol. 2011;38:2172–9.

Article  PubMed  PubMed Central  Google Scholar 

Kubo S, Smith V, Cutolo M, Tanaka Y. The role of nailfold videocapillaroscopy in patients with systemic sclerosis. Immunol Med. 2018;41:113–9.

Article  PubMed  Google Scholar 

Huez S, Roufosse F, Vachiéry JL, Pavelescu A, Derumeaux G, Wautrecht JC, et al. Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Eur Respir J. 2007;30(5):928–36.

Article  CAS  PubMed  Google Scholar 

Naeije R, Saggar R, Badesch D, Rajagopalan S, Gargani L, Rischard F, et al. Exercise-Induced pulmonary hypertension: translating pathophysiological concepts into clinical practice. Chest. 2018;154(1):10–5.

Article  PubMed  Google Scholar 

Coulis A, Levanon S, Randhawa G, Brailovsky Y, Raza F, Oliveros E. Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Front Sports Act Living. 2024;6:1477562.

Article  PubMed  PubMed Central  Google Scholar 

vascular disease in. Pulmonary hypertension due to left heart disease: pathophysiologic implications. Eur Heart J. 2022;43(36):3417–31.

Article  Google Scholar 

Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Retrospective study of clinical and laboratory features in Japanese scleroderma patients with cardiac involvement. J Dermatol Sci. 2009;55:70–2.

Article  PubMed  Google Scholar 

Kanazawa Y, Goda A, Mohri T, Takeuchi S, Takeuchi K, Kikuchi H, et al. Exercise pulmonary hypertension in patients with systemic sclerosis based on updated guidelines. Sci Rep. 2024;14(1):13358.